Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An improved device for potentiometry using magnetic circular dichroism spectroscopy has been developed and used to characterize the potentiometric behavior of solubilized beef heart cytochrome oxidase. In the absence of inhibitors, the electron affinity of cytochromes alpha and alpha 3 are indistinguishable and adequately described by the allosteric model of Nicholls and Peterson (Nicholls, P., and Peterson, L. C. (1972) Biochim. Biophys. Acta 357, 462-467). All of the
cytochrome
alpha can be accounted for as low spin heme throughout the titration. Cytochrome c present at 1:1, 2:1, and 4:1 stoichiometry with
cytochrome
alpha did not significantly affect the potentiometric behavior of alpha or
chondroitinase
alpha 3; at the 1:1 ratio the midpoint potential of cytochrome c was lowered by about 30 mV. In the presence of formate, azide and cyanide
cytochrome
alpha assumed approximately n = 1 behavior. However, the response of alpha 3 differed with each reagent and was particularly complex in the presence of azide. Fluoride produced very small changes in the potentiometric behavior suggesting that it may not be a ligand to
cytochrome
alpha 3. Possible deficiencies in the allosteric model are examined.
...
PMID:Further characterization of the potentiometric behavior of cytochrome oxidase. Cytochrome alpha stays low spin during oxidation and reduction. 631 78